A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease

Respir Med. 1996 Sep;90(8):497-9. doi: 10.1016/s0954-6111(96)90178-x.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adrenergic beta-Agonists / therapeutic use*
  • Adult
  • Albuterol / analogs & derivatives*
  • Albuterol / therapeutic use
  • Bronchodilator Agents / therapeutic use*
  • Cross-Over Studies
  • Drug Therapy, Combination
  • Humans
  • Ipratropium / therapeutic use*
  • Lung Diseases, Obstructive / drug therapy*
  • Male
  • Salmeterol Xinafoate
  • Single-Blind Method

Substances

  • Adrenergic beta-Agonists
  • Bronchodilator Agents
  • Salmeterol Xinafoate
  • Ipratropium
  • Albuterol